Antibiotice Ia Cash Flow Reinvestment Rate

Latest as of June 2026: 2.63x

Antibiotice Ia cash flow reinvestment rate. Antibiotice Ia (ATB) has a Cash Flow Reinvestment Rate of 2.63x as of June 2026, reinvesting RON49.25 Million (capex RON49.25 Million ) from operating cash flow of RON18.71 Million. Explore ATB operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

2.63x
(Capex + Investments) / Operating CF

Total Reinvested

RON49.25 Million
Capex + Investments

Operating Cash Flow

RON18.71 Million
RON

Capital Expenditures

RON49.25 Million
RON

Cash Flow Reinvestment Rate of Antibiotice Ia (2022–2025)

Cash flow reinvestment rate of Antibiotice Ia from 2022 to 2025. Historical reinvestment intensity for Antibiotice Ia across 4 annual periods. Explore Antibiotice Ia capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Antibiotice Ia Cash Flow Reinvestment Rate by Year (2022–2025)

Antibiotice Ia cash flow reinvestment rate by year from 2022 to 2025. Year-by-year capital reinvestment analysis for Antibiotice Ia. For the full cash flow conversion analysis, see ATB cash flow conversion.

Year Reinvestment Rate Total Reinvested (RON) Operating CF Capex YoY Change
2025 1.97x RON142.61 Million RON72.44 Million RON142.61 Million ▼ -19.4%
2024 2.44x RON232.32 Million RON95.15 Million RON116.16 Million ▲ +52.5%
2023 1.60x RON196.07 Million RON122.46 Million RON98.04 Million ▲ +132.2%
2022 0.69x RON79.76 Million RON115.66 Million RON39.88 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow